Krystal Biotech, Inc. (KRYS) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin 55.43%.
- 2026-03-31: Pre-Tax Margin 52.80%.
- 2025-12-31: Pre-Tax Margin 47.74%.
- 2025-09-30: Pre-Tax Margin 49.05%.
Complete source-backed pre-tax margin history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | 55.43% |
| 2026-03-31 | 52.80% |
| 2025-12-31 | 47.74% |
| 2025-09-30 | 49.05% |
| 2025-06-30 | 48.70% |
| 2025-03-31 | 49.44% |
| 2024-12-31 | 53.34% |
| 2024-09-30 | 35.51% |
| 2024-06-30 | 22.83% |
| 2024-03-31 | 2.06% |
| 2023-12-31 | 25.29% |
| 2023-09-30 | 943.75% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | 48.69% |
| 2024-12-31 | 32.82% |
| 2023-12-31 | 25.44% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |